GILEAD SCIENCES, INC. — Director's Dealing 2018

Jan 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-01-11

Reporting Person: Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-11	Common Stock	M	7501	$24.905	Acquired	57114	Direct
2018-01-11	Common Stock	M	18374	$40.56	Acquired	75488	Direct
2018-01-11	Common Stock	S	7501	$79.00	Disposed	67987	Direct
2018-01-11	Common Stock	S	18374	$79.00	Disposed	49613	Direct
2018-01-11	Common Stock	S	4125	$79.00	Disposed	45488	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-11	Non-qualified Stock Option (Right to Buy)	$24.905	M	7501	Disposed	2019-07-29	Common Stock (7501)	Direct
2018-01-11	Non-qualified Stock Option (Right to Buy)	$40.56	M	18374	Disposed	2023-02-01	Common Stock (18374)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.